Library / Laws / 119th Congress / Senate Bills / S. 3510
S. 3510
To improve the inspections of drug establishments engaged in the manufacture, preparation, propagation, or processing of biosimilar biological products conducted by the Food and Drug Administration, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2025-12-16 | 4.6K | ⠃⠗⠋ |